losses from such assets disposition in statement of income for the year ended 31 December 2018 of Baht 56.3 million (after deduction of selling expenses related) which is main reason of net loss increase
subsidiaries’ total earnings amount to Baht 169 million, consisting of Baht 168 million contract revenue and Baht 1 million of other income and interest. This is a decrease of Baht 166 million (50%) from Q3/2018
Research and Development) million baht 8,180 7,378 6,976 Operating expenses (including Research and Development) to sales (%) 16.00% 13.90% 14.17% Operating profit margin (%) 4.48% 8.94% 11.32% Other income
income totaling Baht 47.79 million was mainly affected by the discontinue of profits from sale of investment assets which had occurred only in the year 2018. Nevertheless, Asia Medical & Agricultural
950 million, consisting of Baht 888 million of contract revenue, Baht 55 million of gain on sales of land and Baht 7 million of other income and interest. This is an increase of Baht 70 million (8
service income for the year-ended 31 December 2019 was 800.8 million baht compared to 1,220.6 million baht for the year-ended 31 December 2018, decreased 419.8 million baht or 34.4 percent. It was mainly
2017. The MD&A would enable the investors to better understand the Company and its subsidiaries’ 2nd quarter of 2017 reviewed financial statements. An Analysis of Performance * Analysis of Income The
. 8.01 6.66 1.35 20.27 Total revenue from sales 144.72 176.54 (31.82) (18.02) Services Income - 0.09 (0.09) (100.00) Less Returns in / Discount. 11.31 4.05 (7.26) (179.26) Total Incomes from sales and
% increase from increase from the same period last year. Additional income from 2 subsidiaries is 1. AVF increase over the same period of the previous year 1 3 .6 6 million baht from BRAND ECCO , KEEN and 2
Revenues 321.05 350.25 (8.34) Total Expenses (302.29) (335.59) (9.92) Finance Costs (6.01) (6.61) (9.08) Profit before Income Tax Expenses 12.75 8.06 58.19 Income Tax Expensed (2.61) (0.79) 230.38 Net Profit